Suzuken Co., Ltd. (TYO:9987)
4,806.00
-94.00 (-1.92%)
Aug 5, 2026, 3:30 PM JST
Suzuken Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 2,486,647 | 2,486,647 | 2,399,952 | 2,386,493 | 2,314,828 | 2,232,774 |
Revenue Growth | 3.61% | 3.61% | 0.56% | 3.10% | 3.67% | 4.91% |
Gross Profit Gross Profit Growth | 192,525 | 192,525 | 192,232 | 185,249 | 179,695 | 160,994 |
Operating Income Operating Income Growth | 36,376 | 36,376 | 37,126 | 34,876 | 32,606 | 13,778 |
Net Income Net Income Growth | 38,136 | 38,136 | 34,496 | 29,016 | 20,345 | 14,393 |
Earnings Per Share EPS Growth | 545.54 | 545.54 | 454.58 | 357.87 | 236.46 | 163.18 |
EPS Growth | 20.01% | 20.01% | 27.02% | 51.34% | 44.91% | 84.35% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Healthcare Related Services Healthcare Related Services Growth | 42,964 | 42,964 | 42,188 | 261,604 | 228,691 | 181,761 |
Healthcare Product Development Healthcare Product Development Growth | 51,636 | 51,636 | 52,613 | 51,296 | 44,382 | 43,938 |
Specialty Drug Contract Distribution Business Specialty Drug Contract Distribution Business Growth | 436,100 | 436,100 | 295,485 | - | - | - |
Community Healthcare and Nursing Care Support Business Community Healthcare and Nursing Care Support Business Growth | 93,937 | 93,937 | 94,414 | 97,463 | 87,742 | 88,821 |
Pharmaceutical Distribution Pharmaceutical Distribution Growth | 2,401,013 | 2,401,013 | 2,313,967 | 2,299,180 | 2,226,918 | 2,144,335 |
Intersegment sales and transactions Intersegment sales and transactions Growth | -539,004 | -539,004 | -398,718 | -323,051 | -272,907 | -226,081 |
Total Total Growth | 2,486,646 | 2,486,646 | 2,399,949 | 2,386,492 | 2,314,826 | 2,232,774 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 141,671 | 141,671 | 141,582 | 242,112 | 192,703 | 201,463 |
Total Debt Total Debt Growth | - | - | - | - | - | - |
Net Cash (Debt) Net Cash Growth | 141,671 | 141,671 | 141,582 | 242,112 | 192,703 | 201,463 |
Net Cash Growth | 0.06% | 0.06% | -41.52% | 25.64% | -4.35% | -5.02% |
Net Cash Per Share Net Cash Per Share Growth | 2026.62 | 2026.62 | 1865.72 | 2986.12 | 2239.72 | 2284.08 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 33,566 | 33,566 | -65,079 | 87,216 | 37,270 | 9,520 |
Capital Expenditures CapEx Growth | -15,064 | -15,064 | -14,307 | -10,810 | -15,058 | -11,155 |
Free Cash Flow Free Cash Flow Growth | 18,502 | 18,502 | -79,386 | 76,406 | 22,212 | -1,635 |
Free Cash Flow Growth | - | - | - | 243.98% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 7.74% | 7.74% | 8.01% | 7.76% | 7.76% | 7.21% |
Operating Margin | 1.46% | 1.46% | 1.55% | 1.46% | 1.41% | 0.62% |
Pretax Margin | 2.18% | 2.18% | 2.10% | 1.79% | 1.32% | 1.01% |
Profit Margin | 1.53% | 1.53% | 1.44% | 1.22% | 0.88% | 0.65% |
FCF Margin | 0.74% | 0.74% | -3.31% | 3.20% | 0.96% | -0.07% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 120.000 | 100.000 | 100.000 | 80.000 | 72.000 | 72.000 |
Dividend Per Share Growth | 10.00% | 0% | 25.00% | 11.11% | 0% | 0% |
Dividend Yield | 2.45% | 1.69% | 2.06% | 1.79% | 2.27% | 2.14% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 8.81 | 10.53 | 10.32 | 12.41 | 13.60 | 22.18 |
Forward PE | 13.02 | 13.58 | 14.16 | 16.95 | 13.86 | 20.76 |
P/FCF Ratio | 17.57 | 21.70 | - | 4.71 | 12.46 | - |
PS Ratio | 0.13 | 0.16 | 0.15 | 0.15 | 0.12 | 0.14 |